{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:58Z","timestamp":1790702218446,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/23764-3"],"award-info":[{"award-number":["2012\/23764-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/15134-2"],"award-info":[{"award-number":["2013\/15134-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/22451-7"],"award-info":[{"award-number":["2014\/22451-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jconrel.2018.05.038","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T12:36:54Z","timestamp":1527856614000},"page":"151-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection"],"prefix":"10.1016","volume":"283","author":[{"given":"Raquel","family":"Petrilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josimar O.","family":"Eloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano P.","family":"Saggioro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deise L.","family":"Chesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Claro","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos V.S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis L.P.","family":"daSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-6711","authenticated-orcid":false,"given":"Renata F.V.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.05.038_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.prp.2011.03.002","article-title":"Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy","volume":"207","author":"Uribe","year":"2011","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaad.2017.01.015","article-title":"The adverse prognostic effect of tumor budding on the evolution of cutaneous head and neck squamous cell carcinoma","volume":"76","author":"Gonzalez-Guerrero","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oraloncology.2016.10.006","article-title":"Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population","volume":"63","author":"Fern\u00e1ndez-Mateos","year":"2016","journal-title":"Oral Oncol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejca.2015.06.110","article-title":"Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline","volume":"51","author":"Stratigos","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1634\/theoncologist.2009-0210","article-title":"Treatment of Unresectable and metastatic cutaneous squamous cell carcinoma","volume":"15","author":"Cranmer","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0030","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/1097-0142(19901015)66:8<1692::AID-CNCR2820660807>3.0.CO;2-Y","article-title":"Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil and bleomycin","volume":"66","author":"Sadek","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0035","first-page":"22","article-title":"Considerations for use of fluorouracil cream 0.5% for the treatment of actinic keratosis in elderly patients","volume":"1","author":"Werschler","year":"2008","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0040","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1634\/theoncologist.2012-0458","article-title":"Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer","volume":"18","author":"Cohen","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.critrevonc.2008.07.006","article-title":"The biological properties of cetuximab","volume":"68","author":"Vincenzi","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.critrevonc.2017.04.011","article-title":"Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN); a new perspective in the era of immunotherapy","volume":"115","author":"Saba","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7150\/jca.3491","article-title":"Cetuximab in refractory skin cancer treatment","volume":"3","author":"Kalapurakal","year":"2012","journal-title":"J. Cancer"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2014.11.021","article-title":"Stealth anti-CD4 conjugated immunoliposomes with dual antiretroviral drugs - modern Trojan horses to combat HIV","volume":"89","author":"Ramana","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0065","doi-asserted-by":"crossref","first-page":"209205","DOI":"10.1155\/2013\/209205","article-title":"Targeted antiepidermal growth factor receptor (cetuximab) immunoliposomes enhance cellular uptake in vitro and exhibit increased accumulation in an intracranial model of glioblastoma multiforme","volume":"2013","author":"Mortensen","year":"2013","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0070","doi-asserted-by":"crossref","first-page":"26316","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0075","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(13)70383-8","article-title":"Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study","volume":"14","author":"Pivot","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bej.2016.03.013","article-title":"Design and preparation of chimeric hyaluronidase as a chaperone for the subcutaneous administration of biopharmaceuticals","volume":"112","author":"Liu","year":"2016","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejps.2015.06.013","article-title":"Topical therapies for skin cancer and actinic keratosis","volume":"77","author":"Haque","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0090","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1166\/jbn.2015.2139","article-title":"Topical skin cancer therapy using doxorubicin-loaded cationic lipid nanoparticles and iontophoresis","volume":"11","author":"Huber","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145922","article-title":"Iontophoresis improved growth reduction of invasive squamous cell carcinoma in topical photodynamic therapy","volume":"11","author":"Lemos","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0100","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.nano.2016.07.001","article-title":"Effective transcutaneous immunization using a combination of iontophoresis and nanoparticles","volume":"12","author":"Bernardi","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1871520616666160526110913","article-title":"Cetuximab immunoliposomes enhance delivery of 5-FU to skin squamous carcinoma cells","volume":"17","author":"Petrilli","year":"2017","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbamem.2005.02.007","article-title":"Liposomes targeted via two different antibodies: assay, B-cell binding and cytotoxicity","volume":"1711","author":"Laginha","year":"2005","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/bc060174r","article-title":"Synthesis of cetuximab-immunoliposomes via a cholesterol- based membrane anchor for targeted delivery of a neutron capture therapy (NCT) agent to glioma cells","volume":"18","author":"Pan","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0120","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(12)70476-X","article-title":"Tolerability, safety, pharmacokinetics, and effi cacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study","volume":"13","author":"Mamot","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2017.02.020","article-title":"Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy","volume":"115","author":"Eloy","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1242\/jcs.192104","article-title":"CD4 downregulation by the HIV-1 protein Nef reveals distinct roles for the \u03b31 and \u03b32 subunits of the AP-1 complex in protein trafficking","volume":"130","author":"Tavares","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2008.11.002","article-title":"Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity","volume":"134","author":"Taveira","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000274494","article-title":"Excised porcine cornea integrity evaluation in an in vitro model of iontophoretic ocular research","volume":"43","author":"Gratieri","year":"2010","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1520-6017(200105)90:5<545::AID-JPS1012>3.0.CO;2-H","article-title":"Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis","volume":"90","author":"Tang","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0150","first-page":"133","article-title":"Quantification of 5-FU in skin samples for the development of new delivery","volume":"73","author":"Petrilli","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0155","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ijrobp.2004.02.050","article-title":"C225 Antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy","volume":"59","author":"Nakata","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.radonc.2010.04.017","article-title":"Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse","volume":"96","author":"Skvortsova","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1534735412450514","article-title":"Enhancement of antitumor activity of low-dose 5-fluorouracil by combination with Fuzheng-Yiliu granules in hepatoma 22 tumor-bearing mice","volume":"12","author":"Cao","year":"2013","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbiotec.2013.01.003","article-title":"Skin cancer treatment by albumin\/5-Fu loaded magnetic nanocomposite spheres in a mouse model","volume":"164","author":"Misak","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bcp.2009.09.012","article-title":"Efficacy of ST1968 (namitecan) on a topotecan-resistant squamous cell carcinoma","volume":"79","author":"Zuco","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0360-3016(02)04357-2","article-title":"EGFR blockade with ZD1839 (\u201cIressa\u201d) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma","volume":"55","author":"Solomon","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.colsurfb.2016.01.032","article-title":"Co-loaded paclitaxel\/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy","volume":"141","author":"Eloy","year":"2016","journal-title":"Colloids Surfaces B Bioint."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0190","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijpharm.2015.01.016","article-title":"Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells","volume":"479","author":"Limasale","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2003.10.025","article-title":"Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment","volume":"270","author":"Fang","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijpharm.2015.08.094","article-title":"Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin","volume":"495","author":"Charoenputtakun","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0939-6411(03)00021-3","article-title":"Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study","volume":"55","author":"Verma","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1023\/A:1018841111922","article-title":"Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil","volume":"16","author":"Merino","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jps.21817","article-title":"Penetration of nanoparticles and nanomaterials in the skin: fiction or reality?","volume":"99","author":"Baroli","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0220","first-page":"418","article-title":"Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study the sustained release in vitro and in vivo","volume":"12","author":"Sun","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2010.11.018","article-title":"Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy","volume":"150","author":"Thomas","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0230","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jconrel.2003.12.015","article-title":"Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant","volume":"95","author":"Essa","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1523-1747.ep12478060","article-title":"Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode","volume":"97","author":"Cullander","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(09)70034-8","article-title":"Should we be surprised at the paucity of response to EGFR inhibitors?","volume":"10","author":"Gusterson","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0245","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/0959-8049(95)00218-8","article-title":"Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice","volume":"31","author":"Codacci-Pisanelli","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.05.038_bb0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.addr.2012.06.010","article-title":"Finite and infinite dosing: difficulties in measurements, evaluations and predictions","volume":"65","author":"Selzer","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0255","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.1158\/0008-5472.CAN-05-1093","article-title":"Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo","volume":"65","author":"Mamot","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijscr.2012.07.004","article-title":"Ovarian undifferentiated carcinoma with voluminous mesenteric presentation","volume":"3","author":"Salcedo-Hern\u00e1ndez","year":"2012","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0265","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0270","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.det.2014.06.009","article-title":"Iontophoresis for palmar and plantar hyperhidrosis","volume":"32","author":"Pariser","year":"2014","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.jconrel.2018.05.038_bb0275","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.addr.2003.10.026","article-title":"Iontophoretic drug delivery","volume":"56","author":"Kalia","year":"2004","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918303237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918303237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:35:49Z","timestamp":1759160149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918303237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":55,"alternative-id":["S0168365918303237"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.038","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}